Jeffrey Kraws

Jeffrey Kraws

Chairman chez AVIVAGEN INC.

Fortune : 328 224 $ au 31/12/2023

59 ans
Finance
Health Technology
Consumer Services

Profil

Jeffrey J.
Kraws
is the founder of Crystal Research Associates (founded in 2003) where he holds the title of Chief Executive Officer.
He is also the founder of TopHat Capital LLC (founded in 2012) where he holds the title of Partner.
Additionally, he is the founder of Cra Advisors LLC (founded in 2003) where he holds the title of Chief Executive Officer.
Mr. Kraws's current job(s) include being the Independent Chairman at Avivagen, Inc. (since 2013), the Independent Non-Executive Chairman at Theriva Biologics, Inc. (since 2006), a Partner at Phoenix Holdings Ltd.
(US) (since 2015), a Partner at Grannus Securities Pty Ltd.
(since 2015), and a Partner at US Medical Innovations LLC.
Mr. Kraws's former job(s) include being a Managing Director-Healthcare Research at Ryan, Beck & Co., Inc., a Director at Saleen Automotive, Inc. (from 2013 to 2020), a Managing Director & Research Director at Gruntal & Co. LLC, a Director at Innovation1 Biotech, Inc. (from 2021 to 2023), a Senior Analyst at The Buckingham Research Group, Inc., an MD-Healthcare Research Group at First Union Securities, the President of IRG Research Group, the Co-President of The Investor Relations Group, Inc., the President of Ra Medical Systems, Inc. (from 2016 to 2021), and the President-Brokerage & Investment Banking Operation at Abb Aros Securities, Inc.Mr. Kraws's education history includes an MBA degree from Cornell University (conferred in 1988) and an undergraduate degree from State University of New York at Buffalo (conferred in 1986).

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
12/01/2024 1 389 055 ( 6,79% ) 327 817 $ 31/12/2023
25/03/2024 654 ( 0,00% ) 307 $ 31/03/2024
03/03/2023 50 000 ( 0,06% ) 100 $ 31/03/2024

Postes actifs de Jeffrey Kraws

SociétésPosteDébut
THERIVA BIOLOGICS, INC. Chairman 14/05/2012
AVIVAGEN INC. Chairman 14/05/2019
Founder 01/01/2003
Grannus Securities Pty Ltd. Corporate Officer/Principal 01/11/2015
Chief Executive Officer 01/01/2003
Corporate Officer/Principal 01/11/2015
Founder 01/02/2012
Corporate Officer/Principal -
Tous les postes actifs de Jeffrey Kraws

Anciens postes connus de Jeffrey Kraws

SociétésPosteFin
INNOVATION1 BIOTECH INC. Chief Executive Officer 06/12/2022
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Jeffrey Kraws

Formation de Jeffrey Kraws

Cornell University Masters Business Admin
State University of New York at Buffalo Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jeffrey Kraws

Relations

100 +

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
AVIVAGEN INC.

Health Technology

Entreprise privées17

Finance

Retail Trade

Finance

First Union Securities

Finance

IRG Research Group

Finance

Gruntal & Co. LLC

Government

Finance

Theriva Biologics, Inc.

Commercial Services

Health Technology

Finance

Grannus Securities Pty Ltd.

Finance

Innovation1 Biotech, Inc.

Abb Aros Securities, Inc.

Health Technology

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Jeffrey Kraws